School
School of Pharmacy
Department
Pharmaceutical Sciences
Office Location
White 318
Boston
Office Phone Office Phone: 617.751.3019
About
Nihal Mulla is an associate professor of pharmaceutics at MCPHS. He earned his Doctor of Philosophy in pharmaceutical sciences from Mercer University, a Master of Science in pharmaceutical sciences from Creighton University, and a Bachelor of Pharmacy from Mumbai University.
Mulla’s research focuses on drug delivery systems and cancer immunotherapy, with a particular emphasis on nanoformulation development and targeted delivery platforms. His current work investigates innovative therapeutic delivery mechanisms and vaccine development aimed at improving treatment outcomes.
Education
- Ph.D. Pharmaceutical Sciences, Mercer University
- M.S. Pharmaceutical Sciences, Creighton University
- B.Pharm Mumbai University
Research Interests
- Cancer immunotherapy and vaccine development
- Nanoparticle-based drug delivery systems
- Microneedle platforms for transdermal delivery
- Peptide-based therapeutic formulations
- Targeted drug delivery mechanisms
- Biomaterial-based pharmaceutical applications
Featured Affiliations
American Association of Pharmaceutical Scientists (AAPS)
WebsiteEducation
- Ph.D. Pharmaceutical Sciences, Mercer University
- M.S. Pharmaceutical Sciences, Creighton University
- B.Pharm Mumbai University
Research Interests
- Cancer immunotherapy and vaccine development
- Nanoparticle-based drug delivery systems
- Microneedle platforms for transdermal delivery
- Peptide-based therapeutic formulations
- Targeted drug delivery mechanisms
- Biomaterial-based pharmaceutical applications
Publications
- Mulla N, et al. (2023). Boosting In-Vivo Anti-Tumor Immunity with an Oral Microparticulate Breast Cancer Vaccine and Low-Dose Cyclophosphamide. Vaccines, 11(3), 543.
- Vaidya B, et al. (2019). Nintedanib-cyclodextrin complex to improve bio-activity and intestinal permeability. Carbohydrate Polymers, 204, 68-77.
- Parenky AC, et al. (2019). Harnessing T-cell activity against prostate cancer: A therapeutic microparticulate oral cancer vaccine. Vaccine, 37(41), 6085-6092.
- Zaman RU, et al. (2018). Nanoparticle formulations that allow for sustained delivery and brain targeting of the neuropeptide oxytocin. International Journal of Pharmaceutics, 548(1), 698-706.
- Solomon D, et al. (2017). Role of In Vitro Release Methods in Liposomal Formulation Development: Challenges and Regulatory Perspective. AAPS Journal, 19, 1669-1681.
- D'Souza MJ, et al. (2015). Novel approaches and strategies for biologics, vaccines and cancer therapies. Elsevier Inc.